def14a
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
|
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
þ |
|
Definitive Proxy Statement |
|
o |
|
Definitive Additional Materials |
|
o |
|
Soliciting Material Pursuant to §240.14a-12 |
ACCESS PLANS USA, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (check the appropriate box):
þ |
|
No fee required |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. |
|
|
(1) |
|
Title of each class of securities to which transaction applies: o |
|
|
(2) |
|
Aggregate number of securities to which transaction applies: o |
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and
state how it was determined): o |
|
|
(4) |
|
Proposed maximum aggregate value of transaction: o |
|
|
(5) |
|
Total fee paid: o |
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing
by registration statement number, or the Form or Schedule and the
date of its filing. |
|
|
(1) |
|
Amount Previously Paid: |
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
(3) |
|
Filing Party: |
|
|
(4) |
|
Date Filed: |
Dear Shareholder:
You may have heard by now about our proposed merger with
Alliance HealthCard, Inc. We expect that the merger will be
completed in the first calendar quarter of 2009 and, until then,
we will continue to fulfill our corporate governance obligations
to you. To that end, we will conduct our Annual Meeting of
Shareholders on December 30, 2008. If you have not yet
heard about the merger, we encourage you to review our
statements about the merger and our filings with the Securities
and Exchange Commission, all of which may be accessed through
our website: www.accessplansusa.com.
You are cordially invited to attend the 2008 Annual Meeting of
Shareholders (Annual Meeting) of Access Plans USA,
Inc., which will be held at the Wyndham Hotel DFW North,
4441 West John Carpenter Freeway, Irving, Texas 75063 on
December 30, 2008 at 10:00 a.m., local time. The
official Notice of Annual Meeting, together with a proxy
statement and form of proxy, are enclosed. Please give this
information your careful attention.
A number of important matters will be considered at the Annual
Meeting, including the election of directors. The Board of
Directors of Access Plans USA, Inc. urges your careful
consideration of these and the other matters to be presented at
the Annual Meeting.
We invite all shareholders to attend the meeting in person. If
you cannot be present, you may vote by mailing the enclosed
proxy card or by other methods made available by your bank,
broker or nominee. Voting by written proxy will ensure your
representation at the Annual Meeting if you choose not to attend
in person. Please review the instructions on the proxy card or
the information forwarded by your bank, broker or nominee
concerning your voting options. The shareholders attending the
Annual Meeting may vote in person even if they have returned
a proxy.
Sincerely,
Ian R. Stuart,
Interim Chief Executive Officer and President
Irving, Texas
November 24, 2008
ACCESS
PLANS USA, INC.
4929 West Royal Lane,
Suite 200
Irving, Texas 75063
Telephone:
(866) 578-1665
NOTICE OF ANNUAL
MEETING
To be held on December 30,
2008
TO THE SHAREHOLDERS:
Access Plans USA, Inc., will hold its annual shareholders
meeting (the Annual Meeting) at the Wyndham Hotel
DFW North, 4441 West John Carpenter Freeway, Irving, Texas
75063, commencing at 10:00 a.m., local time on
December 30, 2008 to vote on:
1. The election of six directors, each to hold office until
the 2009 annual meeting of shareholders and until her or his
successor is duly elected and qualified;
2. The ratification of Hein & Associates LLP as
the independent registered public accounting firm for
2008; and
3. Any other business that properly comes before the
meeting or any adjournment or postponement of the Annual Meeting.
Access Plans USA shareholders at the close of business on
November 19, 2008, are receiving notice and may vote at the
Annual Meeting. The election of directors will be determined by
a plurality vote. Approval of all other matters properly brought
before the Annual Meeting requires the affirmative vote of a
majority of the shares cast on the proposal.
Your Board of Directors unanimously recommends that you vote
FOR approval of the matters being voted upon.
Your attendance or Proxy is important to assure a quorum at
the Annual Meeting. Shareholders who do not expect to attend the
Annual Meeting in person are requested to complete and return
the enclosed Proxy, using the envelope provided, which requires
no postage if mailed from within the United States. Any person
giving a Proxy has the power to revoke it at any time prior to
its exercise and, if present at the Annual Meeting, may withdraw
it and vote in person. Attendance at the Annual Meeting is
limited to Access Plans USA shareholders, their proxies and
invited guests. All Shareholders are cordially invited to attend
the Annual Meeting.
BY ORDER OF THE BOARD OF DIRECTORS:
Eliseo Ruiz, III,
Secretary and General Counsel
Irving, Texas
November 24, 2008
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
4
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
9
|
|
|
|
|
15
|
|
|
|
|
17
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
19
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
22
|
|
|
|
|
24
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
26
|
|
2
PROXY
STATEMENT
Access Plans USA,
Inc.
4929 West Royal Lane, Suite 200
Irving, Texas 75063
Telephone:
(866) 578-1665
ANNUAL MEETING OF
SHAREHOLDERS
TO BE HELD ON DECEMBER 30,
2008
SOLICITATION
AND REVOCATION OF PROXIES
This Proxy Statement is furnished to the shareholders of Access
Plans USA, Inc. in connection with an Annual Meeting of the
holders of Access Plans USA common stock to be held in the
Wyndham Hotel DFW North, 4441 West John Carpenter Freeway,
Irving, Texas 75063, at 10:00 a.m., local time, on
December 30, 2008 and any adjournment or postponement of
the Annual Meeting. This Proxy Statement and the accompanying
Notice of Annual Meeting of Shareholders and Proxy will be first
mailed on or about November 24, 2008, to Access Plans
USAs shareholders of record on November 19, 2008.
If the accompanying Proxy is properly executed and returned, the
shares of common stock represented by the Proxy will be voted at
the Annual Meeting. If you indicate on the Proxy a choice with
respect to any matter to be voted on, your shares will be voted
in accordance with your choice. If no choice is indicated, your
shares of common stock will be voted FOR
|
|
|
|
|
the election of six directors, each to hold office until the
2009 annual meeting of shareholders and until his successor is
duly elected and qualified; and
|
|
|
|
ratification of Hein & Associates, LLP as the
independent registered public accounting firm for 2008.
|
In addition, your shares will also be considered and voted upon
other business that properly comes before the Annual Meeting or
any adjournment or postponement. Our Board of Directors knows of
no business that will be presented for consideration at the
Annual Meeting, other than matters described in this Proxy
Statement. Once given, you may revoke the Proxy by
|
|
|
|
|
giving written notice of revocation to our Secretary at any time
before your Proxy is voted,
|
|
|
|
executing another valid proxy bearing a later date and
delivering this proxy to our Secretary prior to or at the Annual
Meeting, or
|
|
|
|
attending the Annual Meeting and voting in person.
|
Neither the corporate laws of Oklahoma, the state in which we
are incorporated, nor our Certificate of Incorporation or Bylaws
have any provisions regarding the treatment of abstentions and
broker non-votes. Accordingly, (i) abstentions and broker
non-votes are counted for purposes of determining the presence
of a quorum at the Annual Meeting, (ii) abstentions are
treated as votes not cast but as shares represented at the
Annual Meeting for purposes of determining results on actions
requiring a majority vote (broker non-voted are treated as votes
neither cast nor represented for purposes of such actions), and
(iii) neither abstentions nor broker non-votes are counted
in determining results of plurality votes.
We will bear the expenses of this proxy solicitation, including
the cost of preparing and mailing this Proxy Statement and
accompanying Proxy. These expenses include the charges and
expenses of banks, brokerage firms, and other custodians,
nominees or fiduciaries for forwarding solicitation material
regarding the Annual Meeting to beneficial owners of our common
stock. Our directors or employees may solicit Proxies by mail,
telephone, and personal interview or by other means without
additional compensation, other than reimbursement for their
related out-of-pocket expenses.
3
Methods
of Voting
You may vote by mail, by telephone, over the Internet or in
person at the Annual Meeting.
Voting by Mail. By signing and returning the
proxy card in the enclosed prepaid and addressed envelope, you
are authorizing the individuals named on the proxy card to vote
your shares at the Annual Meeting in the manner you indicate. We
encourage you to sign and return the proxy card even if you plan
to attend the meeting. Please sign and return your proxy card to
ensure that all of your shares are voted.
Voting by Telephone. To vote by telephone,
please follow the instructions included on your proxy card. If
you vote by telephone, you do not need to complete and mail your
proxy card.
Voting over the Internet. You may be eligible
to vote over the internet. If your proxy card includes
instructions on voting over the internet, please follow those
instructions. If you vote over the internet, you do not need to
complete and mail your proxy card.
Voting in Person at the Annual Meeting. If you
plan to attend the Annual Meeting and vote in person, we will
provide you with a ballot at the meeting. If your shares are
registered directly in your name, you are considered the
stockholder of record and you have the right to vote in person
at the Annual Meeting. If your shares are held in the name of
your broker or other nominee, you are considered the beneficial
owner of shares held in street name. As a beneficial owner, if
you wish to vote at the meeting, you will need to bring to the
meeting a legal proxy from your broker or other nominee
authorizing you to vote your beneficially owned shares.
SHAREHOLDERS
ENTITLED TO VOTE
The shareholders entitled to vote at the Annual Meeting are the
holders of record, at the close of business on November 19,
2008 (the Record Date), of 20,269,145 shares of
common stock then outstanding. Each holder of a share of common
stock outstanding on the Record Date will be entitled to one
vote for each share held on each matter presented at the Annual
Meeting. Our officers, directors and nominee directors own of
record, or are deemed to beneficially own, or manage and control
the voting a total of 12,045,570 shares or 59.23% of our
issued and outstanding common stock (11,340,673 shares or
55.95% excluding unexercised options), all of which we
anticipate will be voted in favor of the matters to be voted
upon at the Annual Meeting. There is no cumulative voting with
respect to the election of directors. The presence in person or
by proxy of the holders of a majority of the shares of common
stock outstanding and represented at the Annual Meeting will
constitute a quorum for the transaction of business.
PROPOSAL ONE
ELECTION OF DIRECTORS
Our Bylaws provide that our Board of Directors shall consist of
not less than one and a greater number as determined from time
to time by resolution of our Board. The number of directors is
currently fixed at six. In general, a director holds office for
a term expiring at the next annual meeting of our shareholders
or until her or his successor is duly elected and qualified.
Nominations of candidates for election as our directors may be
made at any meeting of our shareholders by or at the direction
of our Board of Directors or by any shareholder entitled to vote
at the meeting. Our Bylaws provide that our Board will fix the
date of the annual meeting of our shareholders.
Nominees
Our Board of Directors has nominated each of Andrew A. Boemi,
Russell Cleveland, Kenneth S. George, J. French Hill, Kent
H. Webb, M.D., and Nicholas J. Zaffiris, (each, a
Nominee or, collectively, Nominees) for
election as a director for a term expiring in 2009 or until his
successor is elected and qualified or until his earlier death,
resignation or removal. For information about each Nominee, see
Directors.
The persons named as proxies in the accompanying Proxy, who have
been designated by our Board, intend to vote, unless otherwise
instructed in the Proxy, for the election of Messrs. Boemi,
Cleveland, George, Hill, Webb, and Zaffiris. Each of
Messrs. Boemi, Cleveland, George, Hill, Webb, and Zaffiris
are considered independent directors. Should any Nominee become
unable for any reason to stand for election as a director, it is
intended that
4
the persons named in the Proxy will vote for the election of
another person as our Board may recommend. We know of no reason
why the Nominees will be unavailable or unable to serve.
Required
Affirmative Vote
The affirmative vote of the holders of a majority of the shares
of our common stock present in person or by proxy at the Annual
Meeting and entitled to vote, is required for the election of a
director. An abstention from voting and broker non-votes will be
tabulated as a vote withheld on the election, but will be
included in computing the number of shares present for purposes
of determining the presence of a quorum for the Annual Meeting
and whether a nominee has received the vote of a majority of the
shares present at the Annual Meeting.
Recommendation
of Our Board of Directors
Our Board of Directors recommends a vote FOR the
election of Andrew A. Boemi, Russell Cleveland, Kenneth S.
George, J. French Hill, Kent H. Webb, M.D., and Nicholas J.
Zaffiris to our Board. We will vote your proxy accordingly
unless you specify a contrary choice.
BOARD OF
DIRECTORS AND COMMITTEE MATTERS
The following table sets forth information with respect to each
of our directors and nominee directors.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
J. French Hill(2)(4)
|
|
|
51
|
|
|
Non-Executive Chairman of the Board of Directors, Director and
Nominee Director
|
Andrew A. Boemi(2)(3)
|
|
|
63
|
|
|
Director and Nominee Director
|
Russell Cleveland(1)(4)
|
|
|
69
|
|
|
Director and Nominee Director
|
Kenneth S. George(2)(3)
|
|
|
60
|
|
|
Director and Nominee Director
|
Kent H. Webb, M.D.(1)(5)
|
|
|
51
|
|
|
Director and Nominee Director
|
Nicholas J. Zaffiris(1)(3)
|
|
|
44
|
|
|
Director and Nominee Director
|
|
|
|
(1) |
|
Member of the Compensation Committee. |
|
(2) |
|
Member of the Audit Committee. |
|
(3) |
|
Member of the Corporate Governance and Nominating Committee. |
|
(4) |
|
Member of the Executive Committee. |
|
(5) |
|
Medical Director |
Information
About Each Director
J. French Hill joined the board of directors in
January 2003 and was named Chairman of our Board of Directors on
August 20, 2007. In 1999, Mr. Hill founded Delta
Trust & Banking Corp., a privately held banking, trust
and investment brokerage company headquartered in Little Rock,
AR, following a six year career with Arkansas largest
publicly traded holding company, First Commercial Corp. First
Commercial was sold in 1998 to Regions Financial Corp. (RF). As
an executive officer of First Commercial, Mr. Hill was
chairman of the bank holding companys trust division and
its investment brokerage dealer subsidiary from 1995 until 1998.
He also oversaw a number of other staff functions in the company
from 1993 through 1998 including human resources, executive
compensation, bank compliance, credit review and strategic
planning. During the last five years he has served as a member
of the board of directors of these companies: Delta
Trust & Banking Corp. and its affiliates (1999 to
present); Research Solutions LLC, a privately held company in
the clinical trials business (1999 to present), and Syair
Designs LLC, a privately held company in the aircraft lighting
systems business
(2000-2003).
From May 1989 through January 1993, Mr. Hill was a senior
economic policy official in the George H. W. Bush Administration
on the staff of the White House and as deputy assistant
secretary of the U.S. Treasury. Mr. Hill graduated
magna cum laude in economics from Vanderbilt University.
5
Andrew A. Boemi has been a Managing Director of
Turnaround Capital Partners LP, a Chicago-based private equity
firm focused on investments in the lower middle market since
2001. He was a Director of Insurance Capital Management USA Inc.
and serves on the Advisory Board of Gateway Systems, a
privately-held International Treasury and Cash Management
software development firm. Mr. Boemi has served on the
Board of Directors and as Chairman of the Audit Committee of
Ceres Group, Inc., a previously Nasdaq listed insurance holding
company and on the Board of Directors of Pet Ag, a privately
held international manufacturer of milk replacers for pets.
Mr. Boemi is a member of Turnaround Management Association,
and has been a principal of International Agricultural
Investors, LLC since 2007. He is a graduate of Georgetown
University with a B.S. in Economics and Finance and did graduate
work in Finance at Rutgers University.
Russell Cleveland became one of our directors in
September 2005. He is the Founder, President, and Chief
Executive Officer of Renn Capital Group, Inc., a privately held
investment management company. He has held these positions since
1972. Mr. Cleveland has 40 years experience in the
investment business, of which 31 years has been spent as a
portfolio manager specializing in the investment of common
stocks and convertibles of small private and publicly traded
companies. A graduate of Wharton School of Business,
Mr. Cleveland has served as President of the Dallas
Association of Investment Analysts and, during the course of his
career, has served on numerous boards of directors of public and
private companies. Mr. Cleveland currently serves on the
Boards of Directors of Renaissance III, RUSGIT, Cover-All
Technologies, Inc., CaminoSoft Corp., Digital Recorders, Inc.,
Integrated Security Systems, Inc. and BPO, Inc., all of which
are publicly traded companies.
Kenneth S. George became one of our directors in June
2003. Mr. George served two terms as a State Representative
in the Texas House of Representatives from 1999 to 2003. From
1996 until 2001, he was General Partner of Riverside
Acquisitions L.L.C. and was active in commercial real estate,
financial and land transactions. From 1994 through 1995,
Mr. George was Chairman and Chief Executive Officer of
Ameristat, Inc., the largest private ambulance provider in the
state of Texas. From 1988 until 1994, he was Chairman and Chief
Executive Officer of EPIC Healthcare Group, an owner of 36
suburban/rural acute care hospitals with 15,000 employees
and $1.4 billion in revenues. Mr. George has an M.B.A.
from the University of Texas at Austin and a B.A. from
Washington and Lee University.
Kent H. Webb, M.D., one of our founders, has served
as one of our Directors since June 1996 (and Medical Director
since August 2001). He served as Chairman of our Board of
Directors until December 2000 and was a member or general
partner of our predecessors, Advantage Data Systems, Ltd. and
Medicard Plus ADS Limited Partnership. Dr. Webb
is a general and vascular surgeon and is the cofounder and a
director of Surgical Hospital of Oklahoma. He is a Fellow of the
American College of Surgeons and serves as a Clinical Professor
for the University of Oklahoma. Dr. Webb is a past director
of the Smart Card Industry Association, a nonprofit association.
He is a surgical consultant for the Ethicon Division of
Johnson & Johnson Company, a publicly-held
pharmaceutical and consumer products company. Dr. Webb
graduated from the University of Oklahoma College of Medicine
and completed his residency in General and Vascular Surgery at
the University of Oklahoma Health Services Center.
Nicholas J. Zaffiris became one of our directors in
August 2002. He joined United Healthcare in June 2007, as its
Vice President of Sales and Account Management, Key Accounts,
for its South Florida Health Plan. Until June 2007, he served as
the Vice President of Sales and Account Management at Multiplan,
a privately-held preferred provider organization
(Multiplan), and was responsible for new sales and
existing customer retention and grants to TPAs and employer
groups nationally. Mr. Zaffiris joined Multiplan in early
1998, and has more than 15 years of healthcare experience,
including client management, sales, marketing and customer
service. Before joining Multiplan, he worked for the National
Account Service Company, Blue Cross Blue Shield of Florida, and
served as a Lieutenant in the United States Navy.
Mr. Zaffiris received a B.S. in Political Science from the
United States Naval Academy.
Information
Concerning the Board of Directors
Our Board of Directors currently consists of six members, all of
whom qualify as independent within the meaning of the listing
standards of The NASDAQ Stock Market, Inc.
Each nominee director currently serves as a member of our Board
of Directors. During 2007, our Board of Directors held ten
meetings. Each of the Nominees attended at least 75% of the
Board meeting and the meetings of the Committees on which he
served. The Board met in executive session, without members of
management, four times.
6
Board
Committees
Our Board maintains four standing committees: Audit,
Compensation, Corporate Governance and Nominating, and
Executive. The Compensation Committee and Audit Committee were
established in 1999 and the Corporate Governance Committee and
Medical Committee were established in 2003. In 2004, the
Corporate Governance Committee became the Corporate Governance
and Nominating Committee by action of the Board. The Executive
Committee was established in 2007.
The Executive Committee exercises the authority of the Board of
Directors for matters delegated by the Board in the management
of our business and affairs when the Board is not in session,
but does not set any policy of the Board.
The Audit Committee is responsible for the selection and
retention of our independent auditors, reviews the scope of the
audit function of the independent auditors, and reviews audit
reports rendered by the independent auditors. All of the members
of the Audit Committee are all independent directors
as defined in Rule 4200 of the Nasdaq Stock Market, Inc.
marketplace rules (the Nasdaq rules), and two
members serve as the Audit Committees financial experts.
The Compensation Committee reviews our compensation philosophy
and programs, and exercises authority with respect to payment of
direct salaries and incentive compensation to our officers. A
discussion of the Compensation Committee interlocks and insider
participation is provided below under the section heading
Compensation Committee Interlocks and Insider
Participation.
The Governance and Nominating Committee (a) monitors and
oversees matters of corporate governance, including the
evaluation of Board performance and processes and the
independence of directors, and (b) selects,
evaluates and recommends to the Board qualified candidates for
election or appointment to the Board.
All committees report on their activities to our Board and serve
at the pleasure of our Board. The specific duties and authority
of each committee is set forth in its charters. The charters of
our Audit, Compensation, and Corporate Governance and Nominating
committees are available on the Access Plans USA web site at
www.accessplansusa.com under the section marked investor
relations.
Report of
the Audit Committee
The Audit Committee monitors the integrity of our financial
statements, the independence and qualifications of the
independent registered public accounting firm, our compliance
with legal and regulatory requirements and the effectiveness of
our internal controls. The Audit Committee is also responsible
for retaining, evaluating, and, if appropriate, recommending the
termination of our independent registered public accounting
firm. Our independent registered public accounting firm is
responsible for expressing an opinion on the conformity of our
financial statements with U.S. generally accepted
accounting principles.
Our board of directors has determined that Andrew Boemi and J.
French Hill, two of our independent directors and members of our
audit committee, each qualify as a financial expert.
This determination was based upon Mr. Boemis and
Mr. Hills:
|
|
|
|
|
understanding of generally accepted accounting principles and
financial statements;
|
|
|
|
ability to assess the general application of generally accepted
accounting principles in connection with the accounting for
estimates, accruals and reserves;
|
|
|
|
experience preparing, auditing, analyzing or evaluating
financial statements that present the breadth and level of
complexity of accounting issues that are generally comparable to
the breadth and complexity of issues that can reasonably be
expected to be raised by our financial statements, or experience
actively supervising one or more persons engaged in such
activities;
|
|
|
|
understanding of internal controls and procedures for financial
reporting; and
|
|
|
|
understanding of audit committee functions.
|
7
Mr. Boemis experience and qualification as a
financial expert were acquired through his extensive background
in commercial lending, including management of commercial
lending units of financial institutions, acting as a member of
loan committees, supervising financial analysis, supervising
financial officers and accountants, and overseeing and assessing
company performance. He has served as a seminar lecturer on
accounting and financial matters. Mr. Boemi is currently
Managing Director of a firm that invests in mid-market companies
in early stage turnaround. In this capacity, he evaluates
financial statements and the work of internal accountants and
external auditors. He was previously CEO of a publicly held
multi-bank holding company, supervising the Chief Financial
Officer and the principal officer of the commercial banking
group and interfacing with the companys external auditors.
He previously served as Chairman of the Audit Committee for two
companies. He has a BS degree from Georgetown University in
finance and economics and did graduate work at Rutgers in
banking and finance.
Mr. Hills experience and qualification as a financial
expert were acquired through his extensive background in
financial analysis, investment banking, finance and commercial
banking. He has also participated in the preparation of
financial statements and registration statements filed with the
Securities and Exchange Commission. Mr. Hill also currently
serves on one other audit committees where he has oversight
responsibility of the financial statements and works with the
internal accountants and external auditors on audit
and/or
accounting matters.
In the performance of its functions, our Audit Committee
|
|
|
|
|
reviewed and discussed the audited consolidated financial
statements for 2007 with our management,
|
|
|
|
received the written disclosures and the letter from our
independent registered public accounting firm required by
Independence Standards Board Standard No. 1 and discussed
with the independent registered public accounting firm their
independence, and
|
|
|
|
recommended to our Board of Directors that the audited financial
statements as of and for the year ended December 31, 2007
be included in our annual report on
Form 10-K
for filing with the Securities and Exchange Commission.
|
Our review with the independent registered public accounting
firm included a discussion of such firms judgments as to
the quality, not just the acceptability, of our accounting
principles and other matters as are to be discussed with the
Audit Committee under Statement of Auditing Standards
No. 61. The Audit Committee also discussed with the
independent registered public accounting firm their independence
from us and our management, including disclosures received by
the Audit Committee in accordance with the requirements of the
Independence Standards Board. Furthermore, the Audit Committee
considered whether the non-financial statement audit services
provided by our independent registered public accounting firm
affected their independence. The Audit Committee will discuss
with our independent registered public accounting firm the
overall scope and plans of their audit for 2008.
Each member of the Audit Committee is an independent
director within the meaning of the listing standards of
The Nasdaq Stock Market, Inc. and the rules of the Securities
and Exchange Commission. During 2007, our Audit Committee
formally met 4 times and Mr. Hill, the Chairman of the
Audit Committee and designated financial expert, met with our
registered independent public accounting firm by telephone or in
person on a quarterly basis to discuss our quarterly financial
statements. Our Audit Committee met with our Board of Directors
four (4) times during 2007.
In reliance on the review and discussions referred to above, the
Audit Committee recommended to and our Board of Directors
approved, filing of the audited financial statements for the
year ended December 31, 2007, with the Securities and
Exchange Commission. The Audit Committee selected
Hein & Associates, LLP as our registered independent
public accounting firm for 2008. Representatives of
Hein & Associates, LLP will be present at the Annual
Meeting of Shareholders and will have the opportunity to make a
statement if they so desire and will be available to respond to
appropriate questions from shareholders attending the meeting.
8
Fees for Independent Registered Public Accounting
Firm. The aggregate fees for professional
services rendered to us for the years ended December 31,
2007 and 2006 were as follows:
Audit Fees. During the years ended
December 31, 2007 and 2006, we incurred audit service fees
of $170,000, and $160,000 respectively.
Audit Related Fees. During the years ended
December 31, 2007 and 2006, we incurred audit related fees
of $78,000, and $37,000 related primarily to reviews of SEC
filings, respectively.
All Other Fees. During the years ended
December 31, 2007 and 2006, we incurred other fees of
$55,000 primarily related to the audit of our 401K plan and our
acquisition of ICM, and $215,000 related to our acquisition of
ICM, respectively.
In accordance with our Audit Committee Charter, the Audit
Committee approves in advance any and all audit services,
including audit engagement fees and terms, and non-audit
services provided to us by our independent auditors (subject to
the de minimus exception for non-audit services contained
in Section 10A(i)(1)(B) of the Securities and Exchange Act
of 1934, as amended), all as required by applicable law or
listing standards. The independent auditors and our management
are required to periodically report to the Audit Committee the
extent of services provided by the independent auditors and the
fees associated with these services. In accordance with our
Audit Committee Charter the provision of services by
Hein & Associates, LLP and BDO Seidman, LLP (other
than audit, review or attest services) were approved prior to
the provision of the services and 100% of those services that
were not pre-approved were promptly brought to the attention of
our Audit Committee and approved prior to completion of the
audit of our financial statements for each of 2007 and 2006.
For 2007, all of the services relating to audit-related fees,
tax fees and all other fees were pre-approved by our Audit
Committee or the Chairman of the Audit committee pursuant to
delegated authority.
Our
Audit Committee Members:
J. French Hill, Chairman
Andrew A. Boemi
Kenneth S. George
Report of
the Compensation Committee
Our Compensation Committee reviews and approves compensation and
benefits policies and objectives, determines whether our
executive officers, directors and employees are compensated
according to these objectives, and carries out the
responsibilities of our Board of Directors relating to the
compensation of our executive officers. The Compensation
Committee held two meetings during 2007. The primary goals of
our Compensation Committee in setting executive officer
compensation in 2007 were (i) to provide a competitive
compensation package that enabled us to attract and retain key
executives and (ii) to align the interests of our executive
officers with those of our shareholders and also with our
operating performance. As a result of our merger with ICM in
January 2007, there were a number of changes in our management
and executive officers, including appointment of an Interim
Chief Executive Officer due to the death of Peter W. Nauert, our
former Chief Executive Officer. With the ICM merger we began our
operations in the insurance industry and have reorganized much
of our other operations. Accordingly, we expect that in 2008 our
Compensation Committee will review our current policies and
practices with respect to executive compensation and make
changes as may be necessary to reflect our current position,
including the enactment of formal compensation policies.
Overview
of Executive Compensation
In 2004, we engaged an independent consultant to compare the
primary elements of our executive compensation against a peer
group of comparable companies. Because we were unable to find a
direct peer in our industry of operations with publicly
available information, we relied on a peer group consisting of
(i) national companies in the business services industry
with a market capitalization of less than $100 million,
(ii) companies within the
Dallas-Fort Worth
metropolitan area with revenues of at least $30 million and
no more than $60 million, and with 50 to
500 employees. We also reviewed the information of
publicly-held competitors although these companies did not
9
meet the search criteria. We reviewed a weighted composite of
base pay, incentive compensation and stock options awarded and
created a focal point of total cash compensation that consisted
of base pay and incentive cash compensation. The 2004 study
provided a base of information for subsequent executive
compensation decisions and analysis, but was not the sole factor
in determining executive compensation. Other considered factors
are described below. During 2008, our Compensation Committee
will consider obtaining a study of companies within our current
operating industry that are similar in size, revenues and
earnings to our current profile.
We compete with larger companies for executive level talent.
Accordingly, our Compensation Committee has strived to set
executive compensation at levels and composition that are
comparable to the companies reviewed in the 2004 study.
We have no pre-established policy or target for the allocation
between either cash and non-cash or short-term and long-term
incentive compensation. Our Compensation Committee reviewed the
information from the 2004 study to determine the appropriate
level and mix of incentive compensation. Historically, we made
annual cash incentive awards and non-cash awards on a less
frequent basis. In March 2007, we made one cash award to the
former President and CEO of our Access HealthSource, Inc.
subsidiary (which does business as Foresight TPA,
Foresigfht) in connection with certain amendments to
his employment agreement. Because of the management changes
resulting from our merger with ICM, our acquisition of PME in
October 2007, and other organizational changes, we are
developing new incentive compensation plans that will provide us
with a policy to make cash and non-cash awards as a result of
either our performance or that of our executive officers and
other employees or a combination of both, depending on the type
of award, compared to the established goals.
We believe in engaging the best available talent in critical
managerial functions and this may result in our having to
negotiate individually with executives who have retention
packages in place with other employers or who have specific
compensation requirements. Accordingly, our Compensation
Committee may determine that it is in our and our
shareholders best interests that we negotiate a
compensation package with an individual that deviates from our
standard compensation practices. Similarly, our Compensation
Committee may authorize compensation arrangements outside of the
normal annual review cycle in order to address a retention issue.
In 2007, Peter W. Nauert, who served as our Chief Executive
Officer from January 30, 2007, until his death on
August 19, 2007 did participate in discussions with the
Compensation Committee on executive compensation. We expect that
our Interim Chief Executive Officer, Mr. Stuart, will
participate in these discussions and other members of the
executive management team will participate in the drafting of
our new compensation plans and policies, including our incentive
compensation plan and provide information relating to the
execution of those plans, including earnings targets and
operating results. To the extent that members of management
participate in executive compensation discussions with our
Compensation Committee, they do so only on an advisory basis,
and final determination of executive compensation matters is
made by the Committee.
We currently do not have any ownership guidelines requiring our
executives to hold a minimum ownership interest in our common
stock shares. We believe that our 1999 Stock Option Plan
provides compensation in a manner that aligns the
executives interests with those of our shareholders in our
growth and creation of shareholder value. This plan is discussed
below.
Elements
of Executive Compensation
Compensation of our executive officers in 2007 was comprised
primarily of
|
|
|
|
|
base salary,
|
|
|
|
performance based incentive compensation (bonuses),
|
|
|
|
awards under our equity compensation plans (stock options),
|
|
|
|
perquisites and other employee benefits.
|
In an effort to ensure the continued competitiveness of our
executive compensation policies, the Committee, in setting base
salaries and bonuses and making annual and long-term incentive
awards, considered the prior levels of
10
executive compensation, the compensation paid to executives of
our competitors, the terms of employment agreements and the
previously mentioned 2004 compensation study.
The incentive portions of an executives compensation are
intended to achieve the Committees goal of aligning any
executives interests with those of our shareholders and
with our operating performance. These portions of an
executives compensation are placed at risk and are linked
to the effect our operating results have on the market price of
our common stock and effectively are designed (in the near- and
long-term) to benefit our shareholders through increased value
in the event favorable operating results are achieved. As a
result, during years of favorable operating results our
executives are provided the opportunity to participate in the
increase in the market value of our common stock, much like our
shareholders. Conversely, in years of less favorable operating
results, the compensation of our executives may be below
competitive levels. Generally, higher-level executive officers
have a greater level of their compensation placed at risk.
Executive Base Salaries. We provide a base
salary for our executives to compensate them for their services
during the fiscal year. Because we have a limited number of
employees, we do not have a policy setting forth base salary
ranges by position or responsibility. In determining the base
salary for each employee, the Compensation Committee considers:
|
|
|
|
|
the performance of the executive;
|
|
|
|
our operating performance and results;
|
|
|
|
the 2004 study and other market information; and
|
|
|
|
internal factors including previously agreed upon contractual
commitments, the executives compensation relative to other
officers, and changes in job responsibility.
|
We currently do not have employment agreements with any of our
executive officers. We had an employment agreement in 2007 with
Frank Apodaca, the President and Chief Executive Officer of
Foresight until September 3, 2007, on which date we
terminated his agreement and his employment. We also had an
employment agreement with Robert Bintliff, our Chief Financial
Officer, but the agreement expired on its terms on
October 31, 2007. Mr. Bintliff is no longer employed
by us. He resigned, effective May 28, 2008.
Our executive officers, therefore, are all at-will employees.
The base salary of our General Counsel, Eliseo Ruiz, was
also primarily based on the 2004 compensation study. The base
salaries of Mr. Stuart, our Interim Chief Executive
Officer, Interim President and Chief Financial Officer and of
Mr. Owens, our Chief Marketing Officer, were largely based
on their salaries with ICM prior to our merger with ICM and
reviews of their performance by the Compensation Committee. The
base salary of Mr. Treadway, our Vice President of
Operations, was based on his salary with PME prior to our
acquisition of PME along with the change in his responsibilities
with us, as compared to his responsibilities to PME. The base
salary of Mr. Puestow was based on the then current salary
of the Chief Executive Officer of Foresight, along with
Mr. Puestows experience and special skills and the
fact that Foresight was challenged by the DOJ investigation at
the time of Mr. Puestows hiring.
Incentive Compensation (Bonuses). We have
adopted a formal incentive compensation plan for most of our
executives. The plan promotes high performance and the
achievement of our goals in order to encourage the growth of
stockholder value and allows key employees to participate in our
growth and profitability. However, we do not have current
policies regarding:
|
|
|
|
|
the use of discretion in making awards, the interplay between
the achievement of corporate goals and individual goals,
|
|
|
|
how compensation or amounts realizable from prior compensation
are considered in setting other elements of compensation,
|
|
|
|
the adjustment or recovery of awards or payments if the relevant
company performance measures upon which they were based are
restated or otherwise adjusted in a manner that would reduce the
size of an award or payment, or
|
|
|
|
similar matters related to incentive compensation.
|
11
Instead our Compensation Committee has considered the overall
goals of our compensation program in designing our current
executive incentive compensation plan.
For Mr. Owens and Mr. Treadway, who have
responsibility for our Insurance Marketing and Consumer Plan
Divisions, respectively, their incentive compensation
arrangements are based on meeting division goals for earnings
(adjusted to reflect core earnings from operations). We have set
earnings goals for each division that, upon consolidation, will
return us to profitability in 2008. To the extent that his
division meets its pre-bonus adjusted earnings goal,
Mr. Owens and Mr. Treadway each will receive a
percentage of the divisions adjusted earnings.
Mr. Peustow, who has responsibility for the Regional
Managed Healthcare Division, will be compensated on a
discretionary basis based on the results of that division.
A separate incentive compensation plan has been implemented for
Messrs. Stuart and Ruiz and Ms. Zalud and any other
executives that we may have that do not have profit and loss
responsibility for a division. These executives will participate
in a bonus pool a certain percentage of our pre-bonus core
earnings if we meet certain earnings targets. These bonuses will
be paid in a combination of cash, options to purchase our common
stock shares, and restricted shares of our common stock as the
Compensation Committee may determine and available at the time
of the grant. We currently do not have a plan to issue
restricted stock. If the earnings targets are not met, the
Compensation Committee may award bonuses at its discretion.
In 2007, the Compensation Committee granted only one bonus.
Mr. Apodaca received a cash bonus as a result of a
profitable year in Foresights operation in 2006 and as
consideration for his agreement to amend certain portions of his
employment agreement with us in order to reduce our long-term
obligations under the agreement. In addition, Mr. Owens
received compensation based on the increase in net revenue from
the corresponding prior year period. This plan was established
by ICM prior to our merger and is replaced by the 2008 incentive
compensation plan discussed above.
Long-Term Equity Compensation Plan
Grants. Stock option grants with respect to 2007
performance were made under our 1999 Stock Option Plan to four
employees, including to two executive officers. This Plan
provides for the grant of stock options, with or without stock
appreciation rights. The stock options granted in 2007 were
without stock appreciation rights and have exercise prices equal
to or higher than the fair market value of our common stock on
the date of grant. Because the options were granted with an
exercise price equal to or greater than the market value of our
common stock at the time of grant, they will not provide any
value to the executive until the market price of our common
stock exceeds the option exercise price. These stock options are
accordingly tied to the stock price appreciation of our common
stock value, rewarding the executives and our other employees as
if they share in the ownership of our common stock similar to
that of our shareholders. The number of shares subject to
options granted to each executive officer was determined based
upon the expected value of our common stock and our historical
practice of granting stock options to our executive officers and
directors. Much like our cash incentive compensation, grants
under our 1999 Stock Option Plan are intended to:
|
|
|
|
|
enhance the link between the creation of stockholder value and
long-term executive incentive compensation;
|
|
|
|
provide an opportunity for increased equity ownership by
executives; and
|
|
|
|
maintain competitive levels of executive compensation.
|
The grants made in 2007 to Mr. Treadway and another
employee of PME were made in connection with our acquisition of
PME. The grant made to Mr. Apodaca was in consideration for
his agreement to amend his employment agreement.
Other Benefits. Our executive officers receive
other perquisites and benefits consistent with our goals of
providing an overall compensation plan that is competitive in
order to attract and retain key executives. The Compensation
Committee believes that these perquisites and benefits are
reasonable and periodically reviews our compensation policies.
These perquisites and benefits include health insurance, life
insurance, and other benefits available to all employees of the
Company.
We currently do not have a stock award program, a retirement
plan, a savings plan, a deferred compensation plan, or any other
benefit plan available to our executives, other than our 401(k)
retirement plan that is generally available to our employees.
12
Chief
Executive Officer Compensation
Mr. Nauert served as our Chief Executive Officer from the
date of our merger with ICM, January 30, 2007, until his
death on August 19, 2007. During this time, he had an
annual base salary of $300,000. The base salary was based on
salary, benefits and other compensation provided to
Mr. Nauert by ICM prior to the merger as well as a
consideration of the market value of Mr. Nauerts
extensive experience in the health insurance industry.
Mr. Stuart receives a stipend of $2,000 per month for his
duties as Interim Chief Executive Officer and Interim President
in addition to the base salary of $200,000 that was established
for his duties as Chief Operating Officer.
Post-Employment
Compensation and Contractual Commitments
The Compensation Committee adopted the following policy in 2007
regarding severance payments to executives and other employees:
|
|
|
|
|
Our executive officers will be entitled to severance payment
equal to
3-months
base salary, provided that after five years of service the
severance amount will be equal to
6-months
base salary;
|
|
|
|
Other employees will be entitled to a minimum severance equal to
two weeks base salary, with one week of base salary added
for each year of completed service;
|
|
|
|
Special circumstance may warrant an award greater than or less
than scheduled amount, provided that any deviation for an
executive officer shall be first approved by the Compensation
Committee.
|
The agreements with Messrs. Apodaca and Bintliff provided
that any outstanding stock options held by the executive would
be cancelled in the event that the executive is terminated for
cause. Under the terms of the individual stock option grants, if
the employment relationship is terminated for any other reason,
the executive would have ninety days from the date of
termination to exercise any outstanding options that he is
entitled to exercise (options that are vested).
Summary
Compensation
The following table sets forth the compensation of the
individuals that served as our Chief Executive Officer or our
Chief Financial Officer paid or accrued during 2007 and 2006,
and our two other most highly compensated executive officers
that were serving at December 31, 2007 and another one of
our officers that was not serving as an executive for a portion
of 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
All Other
|
|
|
|
|
Name and Principle Position
|
|
Year
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards(1)
|
|
|
Compensation
|
|
|
Total
|
|
|
Ian R. Stuart(2),
|
|
|
2007
|
|
|
$
|
179,744
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
6,461
|
|
|
$
|
186,205
|
|
Interim Chief Executive Officer, Interim President and Interim
Chief Financial Officer, and Chief Operations Officer
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert L. Bintliff(3),
|
|
|
2007
|
|
|
|
209,212
|
|
|
|
|
|
|
|
|
|
|
|
6,600
|
|
|
|
215,812
|
|
Former Chief Financial Officer and Treasurer
|
|
|
2006
|
|
|
|
187,032
|
|
|
|
75,000
|
|
|
|
116,646
|
|
|
|
7,800
|
|
|
|
386,478
|
|
Frank Apodaca(4),
|
|
|
2007
|
|
|
|
181,935
|
|
|
|
50,000
|
|
|
|
|
|
|
|
41,727
|
|
|
|
273,662
|
|
Former President and Former President of Access HealthSource,
Inc.
|
|
|
2006
|
|
|
|
266,303
|
|
|
|
59,077
|
|
|
|
14,220
|
|
|
|
81,250
|
|
|
|
420,850
|
|
Michael K. Owens(5),
|
|
|
2007
|
|
|
|
159,327
|
|
|
|
|
|
|
|
|
|
|
|
68,304
|
|
|
|
227,631
|
|
Chief Marketing Officer and President of Americas
Healthcare/Rx Plan Agency, Inc.
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eliseo Ruiz III,
|
|
|
2007
|
|
|
|
188,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
188,125
|
|
Vice President, General Counsel and Secretary
|
|
|
2006
|
|
|
|
177,019
|
|
|
|
35,000
|
|
|
|
123,746
|
|
|
|
|
|
|
|
335,765
|
|
Joseph Danko,
|
|
|
2007
|
|
|
|
135,412
|
|
|
|
|
|
|
|
12,064
|
|
|
|
|
|
|
|
147,476
|
|
Controller and Assistant Treasurer
|
|
|
2006
|
|
|
|
113,408
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
123,408
|
|
Peter W. Nauert(6),
|
|
|
2007
|
|
|
|
138,462
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
138,462
|
|
Former Chief Executive Officer and President
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
(1) |
|
We use the binomial lattice option-pricing model to estimate the
option fair values of option awards as described in
Note 2 Summary of Significant Accounting
Policies (Stock Based Compensation) of the financial statements
to arrive at the amounts for Option Awards. |
|
(2) |
|
Mr. Stuart was appointed our Chief Operating Officer at the
time of our merger with ICM on January 30, 2007. He was
appointed Interim Chief Executive Officer and Interim President
on August 20, 2007, following the death of our former Chief
Executive Officer, Peter W. Nauert. For his duties as Interim
Chief Executive Officer and Interim President, Mr. Stuart
receives a stipend in the amount of $2000 per month. That
stipend is reflected as all other compensation. He
was appointed our Chief Financial Officer on May 28, 2008. |
|
(3) |
|
Mr. Bintliffs other compensation reflects
a car allowance of $650 per month that was provided to him until
the expiration of his employment agreement on October 31,
2007. The stipend was then incorporated into his base salary.
Mr. Bintliff resigned from his employment with us,
effective May 28, 2008. |
|
(4) |
|
In March 2007, we renegotiated Mr. Apodacas
employment agreement. As a result of that renegotiation, he was
issued options to purchase 50,000 shares of our common
stock for $2.23 per share. The amount for option awards reflects
the value of those options. Also in connection with the
renegotiation of his agreement, Mr. Apodaca was awarded a
vehicle that had been owned by us and provided to him for use.
The value of that vehicle is included in the other
compensation amount. Finally, in connection with the
renegotiation of his employment agreement and as a result of the
performance of Foresight TPA in 2006, he was awarded a bonus of
$50,000. We terminated Mr. Apodacas employment and
his employment agreement as of September 3, 2007. |
|
(5) |
|
Mr. Owens other compensation is variable commission
compensation based on an increase in
quarter-to-quarter
earnings of AHCP. This incentive compensation plan was
established by ICM prior to our merger with them and has been
replaced by Mr. Owens 2008 incentive compensation
plan described above. |
|
(6) |
|
Mr. Nauert was our Chief Executive Officer and President
from our merger with ICM on January 30, 2007 until his
death on August 19, 2007. His base salary reflects salary
paid directly by us from March 2, 2007 through
August 19, 2007. Mr. Nauert received no base salary
prior to March 2, 2007. Prior to our merger with ICM, ICM
compensated him through other benefits. |
Grants
of Plan-Based Awards
The following table sets forth certain information relating to
options granted in 2007 to named officers to purchase shares of
our common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Stock
|
|
|
|
|
Name
|
|
Grant Date
|
|
|
Option Shares
|
|
|
Exercise Price
|
|
|
Frank Apodaca(1)
|
|
|
03/26/07
|
|
|
|
50,000
|
|
|
$
|
2.23
|
|
J. Scott Treadway(2)
|
|
|
10/30/07
|
|
|
|
120,000
|
|
|
$
|
1.50
|
|
|
|
|
(1) |
|
Mr. Apodacas employment was terminated by us and
these options have been forfeited. |
|
(2) |
|
These options were issued to Mr. Treadway in connection
with our acquisition of PME, his former employer. |
Option
Exercises in Last Fiscal Year
During 2007, no options to purchase our common stock were
exercised by our executive officers.
14
Outstanding
Equity Awards at Fiscal Year-End
The following table sets forth information related to the number
and value of options held by the named officers at
December 31, 2007. No other executive officers held options
at December 31, 2007. During 2007, no options to purchase
our common stock were exercised by the named executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Underlying Unexercised
|
|
|
|
|
|
|
|
|
|
Options as of
|
|
|
Option
|
|
|
Option
|
|
|
|
December 31, 2007
|
|
|
Exercise
|
|
|
Expiration
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
Price
|
|
|
Date
|
|
|
Robert L. Bintliff
|
|
|
75,000
|
|
|
|
25,000
|
|
|
|
2.00
|
|
|
|
2/28/2009
|
|
|
|
|
37,500
|
|
|
|
112,500
|
|
|
|
1.76
|
|
|
|
11/2/2011
|
|
Eliseo Ruiz III
|
|
|
100,000
|
|
|
|
|
|
|
|
2.00
|
|
|
|
3/23/2009
|
|
|
|
|
37,500
|
|
|
|
112,500
|
|
|
|
1.76
|
|
|
|
11/2/2011
|
|
J. Scott Treadway
|
|
|
120,000
|
|
|
|
|
|
|
|
1.50
|
|
|
|
10/30/2012
|
|
Mr. Bintliff resigned from his employment with us,
effective May 28, 2008. His options were forfeited.
Compensation
of Directors
During 2007, the members of our board of directors received the
following compensation:
|
|
|
|
|
Each non-employee member received a quarterly payment of $4,000.
|
|
|
|
In addition, each non-employee member received $500 per calendar
quarter for each committee on which he served and an additional
$500 per quarter for each committee for which he served as
chairperson.
|
|
|
|
We reimbursed our members for travel and out of pocket expenses
in connection with their attendance at board meetings.
|
|
|
|
We may occasionally grant stock options to the board members and
following are the options granted in 2007. No options were
granted in 2006.
|
|
|
|
|
|
Director Name
|
|
Options Granted
|
|
|
Andrew A. Boemi
|
|
|
25,000
|
|
Russell Cleveland
|
|
|
25,000
|
|
Kenneth S. George
|
|
|
25,000
|
|
J. French Hill
|
|
|
25,000
|
|
Kent H. Webb, M.D.
|
|
|
37,500
|
|
Nick J. Zaffiris
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
187,500
|
|
|
|
|
|
|
In addition, Mr. Hill receives $2,750 per month as
additional compensation for his duties and responsibilities as
our non-executive Chairman of the Board of Directors. On
October 30, 2007, Mr. Hill was also awarded options
exercisable for the purchase of 25,000 shares of our common
stock at an exercise price $1.06 per share in connection with
his appointment as our non-executive Chairman of the Board of
Directors.
In 2007, the following directors received compensation in the
following aggregate amounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
Option
|
|
|
|
|
Name
|
|
Paid in Cash
|
|
|
Awards(1)
|
|
|
Total
|
|
|
Russell Cleveland
|
|
$
|
19,000
|
|
|
$
|
31,085
|
|
|
$
|
50,085
|
|
Kenneth S. George
|
|
|
20,500
|
|
|
|
31,085
|
|
|
|
51,585
|
|
J. French Hill
|
|
|
34,250
|
|
|
|
31,085
|
|
|
|
65,335
|
|
Kent H. Webb, M.D.
|
|
|
19,000
|
|
|
|
46,503
|
|
|
|
65,503
|
|
Andrew A. Boemi
|
|
|
19,000
|
|
|
|
31,085
|
|
|
|
50,085
|
|
Nicholas J. Zaffiris
|
|
|
19,000
|
|
|
|
46,042
|
|
|
|
65,042
|
|
15
|
|
|
(1) |
|
We used the binomial lattice option-pricing model to estimate
the option fair values as described in Note 2
Summary of Significant Accounting Policies (Stock Based
Compensation) of the financial statements, to arrive at the
amounts for Option Awards set forth above. |
Equity
Compensation Plans
1999 Stock Option Plan. For the benefit of our
employees, directors and consultants, we have adopted the Precis
Smart Card Systems, Inc. 1999 Stock Option Plan (the stock
option plan or the plan). The plan provides
for the issuance of options intended to qualify as incentive
stock options for federal income tax purposes to our employees
and non-employees, including employees who also serve as our
directors. Qualification of the grant of options under the plan
as incentive stock options for federal income tax purposes is
not a condition of the grant and failure to so qualify does not
affect the ability to exercise the stock options. The number of
shares of common stock authorized and reserved for issuance
under the plan is 1,400,000.
Our board of directors administers and interprets the plan
(unless delegated to a committee) and has authority to grant
options to all eligible participants and determine the types of
options granted, the terms, restrictions and conditions of the
options at the time of grant.
The exercise price of options may not be less than 85% of the
fair market value of our common stock on the date of grant of
the option and to qualify as an incentive stock option may not
be less than the fair market value of common stock on the date
of the grant of the incentive stock option. Upon the exercise of
an option, the exercise price must be paid in full, in cash, in
our common stock (at the fair market value thereof) or a
combination thereof.
Options qualifying as incentive stock options are exercisable
only by an optionee during the period ending three months after
the optionee ceases to be our employee, a director or
non-employee service provider. However, in the event of death or
disability of the optionee, the incentive stock options are
exercisable for one year following death or disability and in
the event of the retirement of the optionee, the Board of
Directors may designate an additional period for exercise. In
any event options may not be exercised beyond the expiration
date of the options. Options may be granted to our key
management employees, directors, key professional employees or
key professional non-employee service providers, although
options granted non-employee directors do not qualify as
incentive stock options. No option may be granted after
December 31, 2008. Options are not transferable except by
will or by the laws of descent and distribution.
All outstanding options granted under the plan will become fully
vested and immediately exercisable if (i) within any
12-month
period, we sell an amount of common stock that exceeds 50% of
the number of shares of common stock outstanding immediately
before the
12-month
period or (ii) a change of control occurs. For
purposes of the plan, a change of control is defined
as the acquisition in a transaction or series of transactions by
any person, entity or group (two or more persons acting as a
partnership, limited partnership, syndicate or other group for
the purpose of acquiring our securities) of beneficial ownership
of 50% or more (or less than 50% as determined by a majority of
our directors) of either the then outstanding shares of our
common stock or the combined voting power of our then
outstanding voting securities.
2002 Non-Employee Stock Option Plan. Effective
May 31, 2002 our board of directors approved the Access
Plans 2002 Non-Employee Stock Option Plan (the 2002 Stock
Option Plan) which was approved by our stockholders on
July 29, 2002 and amended by our stockholders on
January 30, 2007. Our employees who also serve as our
directors are not eligible to receive stock options under this
plan. The purpose of the 2002 Stock Option Plan is to strengthen
our ability to attract and retain the services of individuals
that serve as our non-employee directors, consultants and other
advisors that are essential to our long-term growth and
financial success and thereby to enhance stockholder value
through the grant of stock options. The total number of shares
of common stock authorized and reserved for issuance upon
exercise of options granted under the 2002 Stock Option Plan
is 1,500,000.
Our Board of Directors administers and interprets the 2002 Stock
Option Plan and has authority to grant options to eligible
recipients and determine the basis upon which the options are to
be granted and the terms, restrictions and conditions of the
options at the time of grant. Options granted are exercisable in
such amounts, at such intervals and upon such terms as the
option grant provides. The per share purchase price of the
common stock
16
under the options is determined by our board of directors;
however, the purchase price may not be less than the closing
sale price of our common stock on the date of grant of the
option. Upon the exercise of an option, the stock purchase price
must be paid in full, in cash by check or in our common stock
held by the option holder for more than six months or a
combination of cash and common stock.
Options granted under the 2002 Stock Option Plan may not under
any circumstance be exercised after 10 years from the date
of grant and no option may be granted after March 31, 2010.
Options are not transferable except by will, by the laws of
descent and distribution, by gift or a domestic relations order
to a family member. Family member transfers include
transfers to parents (and in-laws), to nieces and nephews
(adopted or otherwise) as well as trusts, foundations and other
entities principally for their benefit.
Employment
Arrangements and Lack of Keyman Insurance
As of December 31, 2007, we had no employment agreement
with any executive officers of the Company. During 2007, we did
have employment agreements with each of Frank Apodaca and Robert
L. Bintliff. Mr. Apodacas agreement and his
employment were terminated by us as of September 3, 2007.
Mr. Bintliffs agreement expired on its own terms on
October 31, 2007. He resigned from his employment by us,
effective May 28, 2008. As of the date of this report, we
do not maintain any keyman insurance on the life or disability
of our executive officers.
As of the date of this report, we have at will
employment relationship with our other executive officers, with
base salaries as set forth on the table below. Each such officer
is entitled to participate in employee benefit programs,
including our 401(k) plan, that we offer to all of our employees
and is also eligible for incentive compensation awards (bonuses)
as may be determined by our Board of Directors. In addition,
each officer is eligible to participate in the applicable
incentive compensation plan. The base salaries of the other
executive officers are:
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Base Salary
|
|
|
Ian R. Stuart
|
|
Interim Chief Executive Officer, Interim President, Interim
Chief Financial Officer, and Chief Operations Officer
|
|
$
|
200,000
|
|
Michael K. Owens, Jr.
|
|
Chief Marketing Officer and President of Americas
Healthcare/Rx Plan Agency
|
|
$
|
175,000
|
|
Michael R. Puestow
|
|
Vice President of Marketing and President of Foresight TPA
|
|
$
|
225,000
|
|
Eliseo Ruiz III
|
|
Vice President, General Counsel and Secretary
|
|
$
|
188,125
|
|
J. Scott Treadway
|
|
Vice President of Operations
|
|
$
|
165,000
|
|
Nancy Zalud
|
|
Vice President of Communications
|
|
$
|
130,000
|
|
Compensation
Committee Interlocks And Insider Participation
Other than Nicholas J. Zaffiris, the members of our Compensation
Committee have not served as one of our officers or been in our
employ. Mr. Zaffiris served as our non-executive Chairman
of the Board of Directors from June 10, 2005 to
January 30, 2007. No member of the Compensation Committee
has any interlocking relationship with any other company that
requires disclosure under this heading. None of our executive
officers have served as a director or member of the compensation
committee of any entity that has one or more executive officers
serving as a member of our Board of Directors or Compensation
Committee.
Conclusion
and Report on Executive Compensation
Our Compensation Committee believes that our executive
compensation arrangements and plans serve our best interests and
those of our shareholders. The Committee takes very seriously
its responsibilities respecting setting and determining the
compensation arrangements with our executive officers.
Accordingly, the Committee continues to monitor and revise the
compensation arrangements and may formulate other plans and
arrangements as necessary to ensure that our compensation system
continues to meet our needs and those of our shareholders.
17
The Compensation Committee, comprised of Chairman Kent H
Webb, M.D., Russell Cleveland, and
Nicholas J. Zaffiris, has reviewed and discussed the
Compensation Discussion and Analysis required by
Item 402(b) of
Regulation S-K
with management and, based on such review and discussion, the
Compensation Committee recommended to the Board that the
Compensation Discussion and Analysis be included in this Annual
Report on
Form 10-K.
Our
Compensation Committee Members:
Kent H. Webb, M.D., Chairman
Russell Cleveland
Nicholas J. Zaffiris
Compliance
with Section 16(a) of the Securities Exchange Act of
1934
Section 16(a) of the Securities Exchange Act of 1934, as
amended, requires our directors, officers, and persons who own
more than 10% of our common stock or other registered class of
our equity securities to file reports of ownership and changes
in ownership with the Securities and Exchange Commission.
Officers, directors and greater than 10% shareholders are
required to furnish us with copies of all Section 16(a)
forms they file.
Based solely on our review of the copies of the forms we
received covering purchase and sale transactions in our common
stock during 2007, we believe that each person who, at any time
during 2007, was a director, executive officer, or beneficial
owner of more than 10% of our common stock complied with all
Section 16(a) filing requirements during 2007.
EXECUTIVE
OFFICERS
Biographical information about our executive officers is
presented below.
Ian R. Stuart has served as our Interim President and
Chief Executive Officer since August 2007 and prior to which he
was our Chief Operating Officer since January 30, 2007. He
has also served as our Interim Chief Financial Officer since
May 28, 2008. He had previously served as the Chief
Financial Officer and Chief Operating Officer of ICM from
October 2004 until its merger with us on January 30, 2007.
Prior to joining ICM, Mr. Stuart was employed by Citigroup,
from 1991 to 2004, principally in various divisional chief
financial officer roles in insurance, banking and commercial
leasing businesses. Mr. Stuart began his professional
career as an accountant in London, England in 1977 and held
several positions at Price Waterhouse from 1981 to 1991.
Mr. Stuart completed a Hatfield College (England)
accounting program in 1976.
Michael K. Owens, Jr. has served as our Chief
Marketing Officer since May 9, 2007. He also serves as
President of Americas Healthcare/Rx Plan Agency, Inc.,
(AHCP), our wholly owned subsidiary. AHCP was a
subsidiary of ICM until our merger with ICM on January 30,
2007. Mr. Owens has been President of AHCP since January
2006. Prior to joining ICM, he served as Vice President of
Corporate Development for Ceres Group, Inc., a publicly-traded
insurance company, from January 1999 through June of 2002. From
December 2003 to February 2005, Mr. Owens served as an
officer of States General Life Insurance Company
(SGLIC). Mr. Owens serves on the board of
directors for one 501(c) (3) organization devoted to
childrens charities and also donates his time to the St.
Jude Childrens Research Hospital and the March of Dimes
Birth Defects Foundation. Mr. Owens received a B.S. in
marketing from the University of Illinois, Chicago, participated
in the Economics program at New York University and received a
MBA in finance from the University of Chicago.
Eliseo Ruiz III has served as our Vice President,
General Counsel and Secretary since December 2003. Mr. Ruiz
has been a practicing attorney since November 1991. He most
recently was Vice President and General Counsel of CyberBills,
Inc. (and its successor entity) in San Jose, California
from 1999 through 2002. He also served as Associate General
Counsel at Concentra, Inc. from 1998 through 1999 and was in
private practice from
18
1991 through 1997. He holds an undergraduate degree (Plan
II) and a law degree from the University of Texas at
Austin. He is a member of the State Bar of Texas.
Nancy L. Zalud has served as our Vice President of
Communications since January 30, 2007. She had served as
Senior Vice President of ICM since February 2005. She is
responsible for corporate communications and marketing
communications for ICM and its subsidiaries and affiliates.
Ms. Zalud has more than 20 years of corporate
communications and insurance industry experience, including
investor relations, public relations and advertising, marketing
communications, policyholder communications and employee
communications. Before joining ICM, she was Senior Vice
President for States General Life Insurance Company from
December 2003 to February 2005. She was a public
relations/corporate communications consultant from June 2002 to
December 2003 and Senior Vice President for Ceres Group, Inc.
from January 2000 to June 2002. Ms. Zalud received a B.S.
in journalism from the University of Illinois. She holds a FLMI
designation from the Life Office Management Association (LOMA).
J. Scott Treadway has served as our Vice President
of Operations since October 2007, when we acquired PME.
Mr. Treadway has been with PME since its formation in 1996,
most recently as its Vice President of Operations and Vice
President of Strategic Initiatives. Mr. Treadway has worked
in the IT design, development and operations management arena
since 1984. He received a B.S. in computer science from Samford
University in Birmingham, Alabama. He also holds an ACS
(Associate Customer Service) designation from the Life Office
Management Association (LOMA).
Michael R. Puestow has served as our Vice President of
Product Development and President of Access HealthSource, Inc.
(which does business as Foresight TPA) since August 2007. He is
also a founder and Chief Marketing Officer of ATLAS Health
Systems in Boston, where he started in 2006. He has also been a
Managing Partner of Windward Consulting Group since 1999. Prior
to that, Mr. Puestow served as officer, partner or director
of several other human resource consulting and executive search
firms. Mr. Puestow holds a B.S. in psychology from North
Dakota State University.
SECURITIES
AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION
PLANS
The following table sets forth as of December 31, 2007,
information related to each category of equity compensation plan
approved or not approved by our stockholders, including
individual compensation arrangements with our non-employee
directors. The equity compensation plans approved by our
stockholders are our 1999 Stock Option Plan, our 2002 Stock
Option Plan and our 2002 IMR Stock Option Plan. All stock
options, warrants and rights to acquire our equity securities
are exercisable for or represent the right to purchase our
common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
Options and Warrants
|
|
|
Remaining Available
|
|
|
|
Number of
|
|
|
|
|
|
for Future Issuance
|
|
|
|
Shares
|
|
|
Weighted Average
|
|
|
Under Equity
|
|
|
|
Underlying
|
|
|
Exercise Price of
|
|
|
Compensation
|
|
Plan Category
|
|
Unexercised
|
|
|
Outstanding
|
|
|
Plans(1)
|
|
|
Equity compensation plans approved by our stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
2002 Non employee stock option plan
|
|
|
575,000
|
|
|
$
|
2.03
|
|
|
|
904,500
|
|
2002 IMR stock option plan
|
|
|
|
|
|
|
|
|
|
|
|
|
1999 stock option plan
|
|
|
742,000
|
|
|
|
1.89
|
|
|
|
603,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,317,500
|
|
|
|
1.95
|
|
|
|
1,507,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The number of shares of our common stock remaining available for
issuance under equity compensation plans is after excluding the
number of securities issuable upon exercise of outstanding
options and warrants. |
19
DIRECTOR
LIABILITY AND INDEMNIFICATION
As permitted by the provisions of the Oklahoma General
Corporation Act, our Certificate of Incorporation eliminates the
monetary liability of our directors for a breach of their
fiduciary duty as directors. However, these provisions do not
eliminate our directors liability
|
|
|
|
|
for a breach of the directors duty of loyalty to us or our
stockholders,
|
|
|
|
for acts or omissions by a director not in good faith or which
involve intentional misconduct or a knowing violation of law,
|
|
|
|
arising under Section 1053 of the Oklahoma General
Corporation Act relating to the declaration of dividends and
purchase or redemption of shares in violation of the Oklahoma
General Corporation Act, or
|
|
|
|
for any transaction from which the director derived an improper
personal benefit.
|
In addition, these provisions do not eliminate liability of a
director for violations of federal securities laws, nor do they
limit our rights or our stockholders rights, in
appropriate circumstances, to seek equitable remedies including
injunctive or other forms of non-monetary relief. These remedies
may not be effective in all cases.
Our bylaws require us to indemnify all of our directors and
officers. Under these provisions, when an individual in his or
her capacity as an officer or a director is made or threatened
to be made a party to any suit or proceeding, the individual may
be indemnified if he or she acted in good faith and in a manner
reasonably believed to be in or not opposed to our best
interest. Our bylaws further provide that this indemnification
is not exclusive of any other rights to which the individual may
be entitled. Insofar as indemnification for liabilities arising
under our bylaws or otherwise may be permitted to our directors
and officers, we have been advised that in the opinion of the
Securities and Exchange Commission the indemnification is
against public policy and is, therefore, unenforceable.
We enter into indemnity and contribution agreements with each of
our directors and executive officers. Under these
indemnification agreements we have agreed to pay on behalf of
the indemnitee, and his or her executors, administrators and
heirs, any amount that he or she is or becomes legally obligated
to pay because the
|
|
|
|
|
indemnitee served as one of our directors or officers, or served
as a director, officer, employee or agent of a corporation,
partnership, joint venture, trust or other enterprise at our
request or
|
|
|
|
indemnitee was involved in any threatened, pending or completed
action, suit or proceeding by us or in our right to procure a
judgment in our favor by reason that the indemnitee served as
one of our directors or officers, or served as a director,
officer, employee or agent of a corporation, partnership, joint
venture, trust or other enterprise at our request.
|
To be entitled to indemnification, indemnitee must have acted in
good faith and in a manner that he or she reasonably believed to
be in or not opposed to our best interests. In addition, no
indemnification is required if the indemnitee is determined to
be liable to us unless the court in which the legal proceeding
was brought determines that the indemnitee was entitled to
indemnification. The costs and expenses covered by these
agreements include expenses of investigations, judicial or
administrative proceedings or appeals, amounts paid in
settlement, attorneys fees and disbursements, judgments,
fines, penalties and expenses of enforcement of the
indemnification rights.
We maintain insurance to protect our directors and officers
against liability asserted against them in their official
capacities for events occurring after June 7, 2001. This
insurance protection covers claims and any related defense costs
of up to $5,000,000 with an additional excess on losses up to
$5,000,000 on excess of $5,000,000, an additional excess on
losses up to $5,000,000 on excess of $10,000,000, and an
additional excess on losses up to $5,000,0000 in excess of
$15,000,000 each based on alleged or actual securities law
violations, other than intentional dishonest or fraudulent acts
or omissions, or any willful violation of any statute, rule or
law, or claims arising out of any improper profit, remuneration
or advantage derived by an insured director or officer.
20
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
The following table presents, as of November 24, 2008,
information related to the beneficial ownership of our common
stock of (i) each person who is known to us to be the
beneficial owner of more than 5% of our common stock,
(ii) each of our directors and the executive officers named
in the Summary Compensation Table (see Item 11.
Executive Compensation), and (iii) all of our
executive officers and directors as a group, together with their
percentage holdings of the outstanding shares. All persons
listed have sole voting and investment power with respect to
their shares unless otherwise indicated, and there are no family
relationships amongst our executive officers and directors. For
purposes of the following table, the number of shares and
percent of ownership of our outstanding common stock that the
named person beneficially owns includes shares of our common
stock that the person has the right to acquire within
60 days of the above-mentioned date pursuant to the
exercise of stock options and warrants, and are deemed to be
outstanding, but are not deemed to be outstanding for the
purposes of computing the number of shares beneficially owned
and percent of outstanding common stock of any other named
person.
Beneficial
Ownership Of Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 24, 2008(1)
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
Beneficial Ownership
|
|
|
|
Shares
|
|
|
Stock
|
|
|
Beneficially
|
|
|
Total
|
|
|
|
|
|
|
Owned of
|
|
|
Option
|
|
|
Owned
|
|
|
Shares
|
|
|
|
|
|
|
Record
|
|
|
Shares
|
|
|
Shares
|
|
|
Owned
|
|
|
Percent(2)
|
|
|
Our Directors:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andrew A. Boemi
|
|
|
80,769
|
|
|
|
25,000
|
|
|
|
|
|
|
|
105,769
|
|
|
|
.52
|
%
|
Russell Cleveland(3)
|
|
|
|
|
|
|
25,000
|
|
|
|
4,455,358
|
|
|
|
4,480,358
|
|
|
|
22.08
|
%
|
Kenneth S. George
|
|
|
3,000
|
|
|
|
55,000
|
|
|
|
|
|
|
|
58,000
|
|
|
|
.29
|
%
|
J. French Hill
|
|
|
7,000
|
|
|
|
80,000
|
|
|
|
|
|
|
|
87,000
|
|
|
|
.43
|
%
|
Kent H. Webb
|
|
|
125,219
|
|
|
|
91,500
|
|
|
|
7,000
|
|
|
|
223,719
|
|
|
|
1.10
|
%
|
Nicholas J. Zaffiris
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
|
|
55,000
|
|
|
|
.27
|
%
|
Our Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ian R. Stuart(4)
|
|
|
889,556
|
|
|
|
|
|
|
|
|
|
|
|
889,556
|
|
|
|
4.42
|
%
|
Robert L. Bintliff(5)
|
|
|
3,000
|
|
|
|
|
|
|
|
|
|
|
|
115,500
|
|
|
|
0.01
|
%
|
William A. Freshwater(6)
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0.0
|
%
|
Michael K. Owens(7)
|
|
|
144,837
|
|
|
|
|
|
|
|
5,533,482
|
|
|
|
5,678,319
|
|
|
|
28.01
|
%
|
Michael R. Puestow(8)
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0.0
|
%
|
Eliseo Ruiz III(9)
|
|
|
4,283
|
|
|
|
212,500
|
|
|
|
|
|
|
|
216,783
|
|
|
|
.69
|
%
|
Scott Treadway(10)
|
|
|
11,000
|
|
|
|
120,000
|
|
|
|
|
|
|
|
131,000
|
|
|
|
.65
|
%
|
Nancy L. Zalud(11)
|
|
|
69,169
|
|
|
|
|
|
|
|
|
|
|
|
69,169
|
|
|
|
.34
|
%
|
Our Executive Officer and Directors as a group of
13 persons
|
|
|
1,344,833
|
|
|
|
664,000
|
|
|
|
9,995,840
|
|
|
|
12,004,673
|
|
|
|
59.23
|
%
|
Other Beneficial Owners:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter W. Nauert Revocable Trust u/a/d 08/07/1978(12)
|
|
|
5,533,482
|
|
|
|
|
|
|
|
|
|
|
|
5,533,482
|
|
|
|
27.30
|
%
|
Ready One Industries
|
|
|
1,961,784
|
|
|
|
|
|
|
|
|
|
|
|
1,961,784
|
|
|
|
9.68
|
%
|
US Special Opportunities Trust PLC(3)
|
|
|
801,813
|
|
|
|
|
|
|
|
|
|
|
|
801,813
|
|
|
|
3.96
|
%
|
Renaissance Capital Growth & Income Fund III,
Inc.(3)
|
|
|
890,500
|
|
|
|
|
|
|
|
|
|
|
|
890,500
|
|
|
|
4.42
|
%
|
Premier RENN US Emerging Growth Fund Limited(3)
|
|
|
1,200,900
|
|
|
|
|
|
|
|
|
|
|
|
1,177,147
|
|
|
|
5.92
|
%
|
Renaissance US Growth & Income Trust PLC(3)
|
|
|
1,562,145,
|
|
|
|
|
|
|
|
|
|
|
|
1,562,145
|
|
|
|
7.71
|
%
|
RENN Capital Group, Inc.(3)
|
|
|
|
|
|
|
25,000
|
|
|
|
4,455,358
|
|
|
|
4,480,358
|
|
|
|
22.08
|
%
|
Rodney D. Baber
|
|
|
1,043,354
|
|
|
|
|
|
|
|
|
|
|
|
1,043,354
|
|
|
|
5.15
|
%
|
21
|
|
|
(1) |
|
Shares not outstanding but deemed beneficially owned by virtue
of the right of the named person to acquire the shares within
60 days of the above-mentioned date are treated as
outstanding for determining the amount and percentage of common
stock owned by the person. Shares for which beneficial ownership
is disclaimed by an individual also are included for purposes of
determining the amount and percentage of Common Stock owned by
such individual. Based upon our knowledge, each named person has
sole voting and sole investment power with respect to the shares
shown except as noted, subject to community property laws, where
applicable. |
|
(2) |
|
The percentage shown was rounded to the nearest one-tenth of one
percent, based upon 20,269,145 shares of common stock being
outstanding on November 24, 2008. |
|
(3) |
|
The 4,480,358 Other Beneficially Owned Shares are
owned by US Special Opportunities Trust PLC
(801,813 shares), Renaissance Capital Growth &
Income Fund III, Inc. (890,500 shares), Premier RENN
US Emerging Growth Fund Limited (1,200,900 shares),
Renaissance US Growth & Income Trust PLC
(1,562,145 shares), each of which is an investment fund
managed by RENN Capital Group, Inc., which also holds options to
purchase 25,000 of our shares. Mr. Cleveland controls RENN
Capital Group, Inc. and is deemed, therefore, to be the
beneficial owner of the common stock shares. |
|
(4) |
|
In January 2007, Mr. Stuart became our Chief Operating
Officer and in August 2007 became the Interim Chief Executive
Officer and President. In May 2008, he was appointed our
Chief Financial Officer. |
|
(5) |
|
Mr. Bintliff was our Chief Financial Officer. The total
beneficially owned shares and percentage of outstanding shares
include 112,500 shares of our common stock issuable upon
exercise of stock options. Mr. Bintliff holds additional
options to purchase 137,500 common stock shares that are not
exercisable and will not be exercisable within 60 days of
the date of this report. Mr. Bintliff resigned from his
employment with us, effective May 28, 2008. His options
have been forfeited. |
|
(6) |
|
In April 2007, Mr. Freshwater became our Vice President of
Sales and Regulatory Counsel. |
|
(7) |
|
In January 2007, Mr. Owens became President of our
Americas Health Care/Rx Plan Agency, Inc. subsidiary that
was acquired as part of our merger acquisition of ICM. The
number of Other Beneficially Owned Shares attributed
to Mr. Owens reflects Mr. Owens sole voting
power as the Trustee of the Peter W. Nauert Revocable Trust, the
record owner of the shares. |
|
(8) |
|
In August 2007, Mr. Puestow became our Vice
President/Product Development and President of our Regional
Health Care Division in El Paso |
|
(9) |
|
Mr. Ruiz is our General Counsel. The total beneficially
owned shares and percentage of outstanding shares include
212,500 common stock shares that are exercisable or will be
exercisable within 60 days of the date of this report.
Mr. Ruiz holds additional options to purchase 37,5000
common stock shares that are not exercisable and will not be
exercisable within 60 days of the date of this report. |
|
(10) |
|
In October 2007, Mr. Treadway became our Vice President of
Operations. |
|
(11) |
|
In January 2007, Ms. Zalud became our Vice President of
Marketing and Communications. |
|
(12) |
|
The shares owned by the Peter W. Nauert Revocable Trust are also
reflected as beneficially owned shares of Mr. Owens because
of Mr. Owens role as Trustee of the trust, in which
capacity he holds sole voting power over the shares. |
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
Our policies with respect to related party transactions are
included in more general conflict of interest policies and
practices set forth in our Code of Conduct.
Our Code of Conduct prohibits conflicts involving family
members, ownership in outside businesses, and outside
employment. Our directors, officers and employees and their
family members are not permitted to own, directly or indirectly,
a significant financial interest in any business enterprise that
does or seeks to do business with, or is in competition with, us
unless prior specific written approval has been granted by our
Board of Directors. As a guide, a significant financial
interest refers to an ownership interest of more than 1%
of the outstanding securities or capital value of the business
enterprise or that represents more than 5% of the total assets
of the director, officer, employee or family member.
22
Our Corporate Governance and Nominating Committee is charged
with reviewing conflicts of interests. If the matter cannot be
resolved by the Committee, our Board of Directors may take
action, or in the case of a conflict among all or nearly all of
the members of our Board of Directors, the matter may be
presented to our shareholders for consideration.
Contained below is a description of transactions and proposed
transactions we entered into with our officers, directors and
stockholders that beneficially own more than 5% of our common
stock during 2007 and 2006 (Related Parties). These
transactions may continue in effect and may result in conflicts
of interest between us and these Related Parties. Although our
officers and directors have fiduciary duties to us and our
stockholders, there can be no assurance that conflicts of
interest will always be resolved in our favor or our
stockholders.
Estate of Peter W. Nauert and the Peter W. Nauert Revocable
Trust. Michael K. Owens is our Chief Marketing
Officer and the President of our AHCP subsidiary. Mr. Owens
is also the personal representative of the Estate of Peter W.
Nauert, our former Chief Executive Officer (the
Estate). We currently have claims against the estate
connected to, among other things, Mr. Nauerts
personal indemnification of us for matters relating to the
States General litigation. Please see Item 3. Legal
Matters in our Annual Report on
Form 10-K
filed with the SEC on April 2, 2008 for more information
about this litigation. Many of the beneficiaries of the Estate
are also beneficiaries of the Peter W. Nauert Revocable Trust
u/a/d
08/07/1978
(the Nauert Trust). Mr. Owens is also the
trustee of the Nauert Trust.
On September 28, 2007, we entered into a loan arrangement
with the Nauert Trust. Under this arrangement, the Nauert Trust
lent us $500,000 as evidenced by the Revolving Promissory Note
(the Note). The Note matures September 28, 2008
and all principal and interest will be due and payable. The
outstanding principal balance of the Note accrues interest at a
rate of 0.5% below the Prime Rate charged by a designated local
bank (6.75% at December 31, 2007). Based upon the current
interest rate, the Note requires 12 monthly principal and
interest payments of $43,321. The Trust holds
5,533,482 shares of our common stock.
The Nauert Trust holds approximately 27% of the Companys
issued and outstanding common stock. The loan arrangement was
entered into with the consent of the Companys Board of
Directors. The Boards Corporate Governance and Nominating
Committee determined that the conflict of interest, if any, of
the Companys Interim President and Chief Executive
Officer, Ian Stuart, with respect to his relationship in the
original financing arrangements, had been properly disclosed and
reviewed and did not preclude the Company from entering into the
loan with the Nauert Trust.
Certain Relationships with NCED. On
June 18, 2004, we acquired Foresight from Ready One
Industries, formerly National Center for Employment of the
Disabled, Inc. (NCED) for a purchase price of
$7,863,000 consisting of cash payments totaling $4,232,000 and
issuance of 2,145,483 common stock shares having a value of
$3,632,000. Frank Apodaca served as Chief Administration Officer
of NCED. Mr. Apodaca previously served as our President and
Chief Operating Officer, and the President and Chief Executive
Officer of Foresight until we terminated his employment as of
September 3, 2007. Pursuant to an agreement with NCED,
Mr. Apodaca was entitled to 10% of the purchase price
received by NCED. This agreement pre-dated our purchase of
Foresight.
Furthermore, the 16,780 square feet of office space we
lease for our Foresight operations in El Paso (see
Item 2. Property) was owned by NCED through
January 2007. The terms of this lease arrangement were
comparable within the local area and consistent with an
arms-length transaction. Total payments of $169,000 were paid to
NCED under this lease agreement in 2006. Foresight also earned
revenue from NCED of $729,000, $684,000, and $146,000 in 2005,
2006 and 2007, respectively.
23
Shares Issued as a Result of our Merger with
ICM. On January 30, 2007, we completed our
merger with ICM. Under the terms of the Merger Agreement, we
issued shares of our common stock to the shareholders of ICM.
Also, pursuant to the Merger Agreement, we issued additional
shares of our common stock to the shareholders of ICM on
May 31, 2007, as a result of ICMs having met certain
earnings targets, as set out in the Merger Agreement. Each of
the ICM shareholders was at the time of the issuance of the
shares one of our officers or directors. Except as noted, each
of the ICM shareholders remains one of our officers or
directors. The following parties received our shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Issued on
|
|
|
Shares Issued on
|
|
Shareholder
|
|
Relationship
|
|
January 30, 2007
|
|
|
May 31, 2007
|
|
|
Peter W. Nauert
|
|
Mr. Nauert was our Chief Executive
|
|
|
3,684,299
|
|
|
|
1,849,183
|
|
Revocable Trust
|
|
Officer from January 30, 2007
|
|
|
|
|
|
|
|
|
U/A/D 08/07/78,
Trustee
|
|
until his death on August 19, 2007
|
|
|
|
|
|
|
|
|
Ian R. Stuart
|
|
Chief Operating Officer and Interim Chief Executive Officer and
President
|
|
|
583,961
|
|
|
|
293,095
|
|
Michael K. Owens
|
|
Chief Marketing Officer and President of AHCP Agency
|
|
|
92,107
|
|
|
|
46,230
|
|
Carl Fischer*
|
|
President of ACP/SCP*
|
|
|
46,054
|
|
|
|
23,115
|
|
Nancy L. Zalud
|
|
Vice President of Communication
|
|
|
46,054
|
|
|
|
23,115
|
|
Andrew A. Boemi
|
|
Director
|
|
|
46,054
|
|
|
|
23,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,498,529
|
|
|
|
2,257,853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
No longer an officer of the company |
Our Relationship with Insurance Producers of America Agency,
Inc. (IPA). Prior to our merger with
ICM, IPA was a subsidiary of ICM. On September 26, 2006,
ICM transferred its ownership interest in IPA to the Nauert
Trust. Ian Stuart, our Interim Chief Executive Officer and
President also owned shares in IPA. Each of the Nauert Trust and
Mr. Stuart retained their respective ownership interest in
IPA after the ICM merger. IPA occupies a portion of our leased
spaced in Irving, Texas and certain of our employees, including
Mr. Stuart, occasionally perform services for IPA. IPA pays
us rent at commercially reasonable rates for the space it
occupies and also pays us for the services of our employees, at
the employees respective hourly rates. In 2008, the
majority of the outstanding common stock of IPA was purchased by
an independent third party, leaving the Nauert Trust with no
ownership interest in IPA and Mr. Stuart with an 11%
ownership interest in IPA. The total amount that we receive from
IPA for the use of its office space and the services of our
employees is usually less than $5000 per month.
Director
Independence
Each member of our Board of Directors qualifies as an
independent director as defined in Rule 4200 of
the Nasdaq Stock Market, Inc. Marketplace Rules (see
Item 10. Directors, Executive Officers and Corporate
Governance, of our Annual Report on
Form 10-K).
PROPOSAL TWO
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
Our Board of Directors has appointed Hein &
Associates, LLP as our independent registered public accounting
firm for the year ending December 31, 2008.
Hein & Associates LLP has been our independent
registered public accounting firm since December 19, 2005.
A proposal will be presented at the Annual Meeting asking you
and our other shareholders to ratify the appointment of
Hein & Associates LLP as our independent registered
public accounting firm. If our shareholders do not ratify the
appointment of Hein & Associates LLP, our Board will
reconsider the appointment.
24
A representative of Hein & Associates LLP will be
present at the Annual Meeting. Such representative will be given
the opportunity to make a statement if he desires to do so and
will be available to respond to appropriate questions.
Required
Affirmative Vote
The affirmative vote of the holders of a majority of the shares
of our common stock present in person or by proxy at the Annual
Meeting and entitled to vote, is required for the adoption of
this proposal. An abstention from voting and broker non-votes
will be tabulated as a vote withheld on the election, but will
be included in computing the number of shares present for
purposes of determining the presence of a quorum for the Annual
Meeting and whether this proposal has received the vote of a
majority of the shares present at the Annual Meeting.
Recommendation
of Our Board of Directors
Our Board of Directors recommends a vote FOR the
ratification of the appointment of Hein &
Associates LLP as our independent registered accounting
firm. We will vote your proxy accordingly unless you specify a
contrary choice.
OTHER
BUSINESS TO BE BROUGHT BEFORE THE MEETING
Our Board of Directors knows of no business that will be
presented for action at the Annual Meeting other than that
described in the Notice of Annual Meeting of Shareholders and
this Proxy Statement. However, if any other matters should
properly come before the Annual Meeting, it is the intention of
the persons named in the accompanying proxy to vote such proxies
as they deem advisable in accordance with their best judgment.
SHAREHOLDER
PROPOSALS FOR 2009 ANNUAL MEETING
Under the existing rules of the Securities and Exchange
Commission, one or more of our shareholders may present
proposals on any matter that is a proper subject for
consideration by our shareholders at the 2009 annual meeting of
our shareholders. In order to be included in the proxy statement
(or disclosure statement in the event proxies are not solicited
by our Board of Directors) for the 2009 annual meeting of our
shareholders, a proposal must be received by April 1, 2009.
It is suggested that if you, as one of our shareholders, desire
to submit a proposal you should do so by sending the proposal
certified mail, return receipt requested, addressed to our
Corporate Secretary at our principal office, 4929 West
Royal lane, Suite 200, Irving, Texas 75063. Detailed
information for submitting proposals will be provided upon
written request, addressed to our Corporate Secretary. As to all
such matters which we do not have notice on or prior to
April 1, 2009, discretionary authority shall be granted to
the persons designated in the proxy related to the 2009 Meeting
to vote on such proposal.
HOUSEHOLDING
INFORMATION
Unless we have received contrary instructions, we may send a
single copy of this proxy statement and notice of annual meeting
to any household at which two or more shareholders reside if we
believe the shareholders are members of the same family. Each
shareholder in the household will continue to receive a separate
proxy card. This process, known as householding,
reduces the volume of duplicate information received at any one
household and helps to reduce our expenses. However, if
shareholders prefer to receive multiple sets of our disclosure
documents at the same address this year or in future years, the
shareholders should follow the instructions described below.
Similarly, if an address is shared with another shareholder and
together both of the shareholders would like to receive only a
single set of our disclosure documents, the shareholders should
follow these instructions:
If the shares are registered in the name of the shareholder, the
shareholder should contact us at our offices at 4929 West
Royal Lane, Suite 200, Irving, Texas 75063, to inform us of
their request. If a bank, broker or other nominee holds the
shares, the shareholder should contact the bank, broker or other
nominee directly.
25
WHERE YOU
CAN FIND MORE INFORMATION
We file annual and quarterly reports and other reports and
information with the Securities and Exchange Commission. These
reports and other information can be inspected and copied at,
and copies of these materials can be obtained at prescribed
rates from, the Public Reference Section of the Securities and
Exchange Commission, Judiciary Plaza, 450 Fifth Street,
N.W., Washington, D.C.
20549-1004.
We distribute to our shareholders annual reports containing
financial statements audited by our independent registered
public accounting firm and, upon request, quarterly reports for
the first three quarters of each fiscal year containing
unaudited financial information. In addition, the reports and
other information are filed through Electronic Data Gathering,
Analysis and Retrieval (known as EDGAR) system and
are publicly available on the Securities and Exchange
Commissions site on the Internet, located at
http://www.sec.gov.
We will provide without charge to you, upon written or oral
request, a copy of the reports and other information filed with
the Securities and Exchange Commission.
Any requests for copies of information, reports or other filings
with the Securities and Exchange Commission should be directed
to Access Plans USA, Inc. at 4929 West Royal Lane,
Suite 200, Irving, Texas 75063, telephone:
(866) 578-1665.
To obtain timely delivery, any information must be requested no
later than five business days before the Annual Meeting.
Your cooperation in giving these matters your immediate
attention and in returning your proxy promptly will be
appreciated.
BY ORDER OF THE BOARD OF DIRECTORS
Eliseo Ruiz III
Vice President, Secretary, and General Counsel
November 24, 2008
A copy of our Annual Report, which includes our
Form 10-K/A
(without exhibits) for the fiscal year ended December 31,
2007, accompanies this Proxy Statement.
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
000004 |
|
|
|
|
|
MR A SAMPLE
DESIGNATION (IF ANY)
ADD 1
ADD 2
ADD 3
ADD 4
ADD 5
ADD 6
|
|
|
|
|
Electronic Voting Instructions
You can vote by Internet or telephone!
Available 24 hours a day, 7 days a
week! Instead of mailing your proxy, you may choose one of
the two voting methods outlined below to vote your proxy.
VALIDATION
DETAILS ARE LOCATED BELOW IN THE TITLE BAR.
Proxies submitted by the Internet or telephone must be received by
1:00 a.m., Central Time, on December 30, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
Vote by
Internet
Log
on to the Internet and go to www.investorvote.com/AUSA
Follow the steps outlined on the secured website. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vote by
telephone
Call toll free 1-800-652-VOTE (8683) within the United
States, Canada &
Puerto Rico any time on a touch tone
telephone. There is NO CHARGE to you for the call. |
|
|
|
|
|
|
|
|
|
|
Using a black ink pen, mark your votes with an X as shown in
this example. Please do not write outside the designated areas.
|
|
|
|
|
|
|
Follow the instructions provided by the recorded message. |
|
|
|
|
Annual Meeting Proxy Card |
|
C0123456789 |
12345
|
|
▼
IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE,
FOLD ALONG THE PERFORATION, DETACH AND RETURN
THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. ▼
A
Proposals The Board of Directors recommends a vote FOR
all the nominees listed and FOR Proposals 2 and 3.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
|
Election of Directors*:
|
|
For
|
|
Withhold
|
|
|
|
For
|
|
Withhold
|
|
|
|
For
|
|
Withhold
|
|
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01 - Andrew A. Boemi
|
|
o
|
|
o
|
|
02 - Russell Cleveland
|
|
o
|
|
o
|
|
03 - Kenneth S. George
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04 - J. French Hill
|
|
o
|
|
o
|
|
05 - Kent H. Webb, M.D.
|
|
o
|
|
o
|
|
06 - Nicholas J. Zaffiris
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
|
* To elect each for a term ending in 2009 and until each of their
respective successors shall have been duly
elected and qualified.
A vote FOR will represent a vote for
the nominee director. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain |
2.
|
|
To ratify the
appointment of Hein
& Associates, LLP
as the Companys
independent
registered public
accounting firm for
the year ending
December 31, 2008.
A vote FOR will
represent a vote
for such
ratification and
appointment.
|
|
o
|
|
o
|
|
o
|
|
|
3. |
|
|
To approve other
business that
properly comes
before the Annual
Meeting or any
adjournment or
postponement. A
vote FOR will
represent a vote
for approval of the
business presented.
|
|
o
|
|
o
|
|
o |
|
|
|
B
Non-Voting
Items |
|
|
Change of Address
Please print new address below.
|
|
|
|
|
C |
Authorized
Signatures
This section must be completed for your vote to be counted.
Date and Sign Below
|
Please sign exactly as the name appears to left. When shares are held by joint tenants, both should sign. When signing as attorney, as executor, administrator, trustee or guardian, please give
full title as such. If a corporation, please sign in full corporate name by president or other authorized officer. If a partnership, please sign in partnership name by authorized person.
|
|
|
|
|
Date (mm/dd/yyyy) Please print date below.
|
|
Signature 1 Please keep signature within the box.
|
|
Signature 2 Please keep signature within the box. |
|
/ / |
|
|
|
|
▼IF
YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.▼
Proxy ACCESS PLANS USA, INC.
4929 West Royal Lane, Suite 200
Irving, Texas 75063
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF ACCESS PLANS USA, INC.
The undersigned hereby acknowledges receipt of the official Notice of Annual Meeting, dated November 24, 2008, and hereby appoints Ian Stuart as Proxy, with the power to appoint his substitute, and hereby appoints and authorizes him to represent and vote as designated below, all the shares of Common Stock, $.01 par value, of Access Plans USA, Inc. (the Company) held of record by the undersigned on
November 19, 2008 at the annual meeting of shareholders to be held at 10:00 a.m. on December 30, 2008, or any adjournment thereof.
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE
UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR PROPOSALS ONE THROUGH THREE.
PLEASE MARK, SIGN, AND DATE AND RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE.
(CONTINUED ON REVERSE SIDE)